This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

4 Stocks Rising on Unusual Volume

Clovis Oncology

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Clovis Oncology (CLVS) is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the U.S., Europe and additional international markets. This stock is trading up 2.6% at $21.15 in recent trading.

Today's Volume: 52,000

Average Volume: 74,313

Volume % Change: 50%

>>22 Biopharma Stocks With Breakout Potential in 2012

From a technical perspective, CLVS is bouncing modestly here right off its 50-day moving average of $18.32 with decent volume. This move is quickly pushing CLVS within range of a near-term breakout trade. That trade will hit once CLVS takes out some near-term overhead resistance at $21.40 with high volume.

Traders should now look for long-biased trades in CLVS as long as its trending above its 50-day, and then once it sustains a move or close above $21.40 with volume that's near or above 74,313 shares. If that breakout triggers soon, then CLVS will have a great chance of re-testing or possibly taking out its next major overhead resistance level at $23.42.
4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CLVS $13.20 -5.40%
DMND $37.56 0.97%
TITN $12.41 -0.80%
SUSS $81.72 -0.32%
AAPL $94.30 -0.92%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs